Cargando…
Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy
Background: 5q spinal muscular atrophy (SMA) is an autosomal recessive lower motoneuron disease caused by deletion or mutations in the survival motor neuron 1 gene (SMN1) which results in reduced expression of full-length SMN protein. The main symptoms are caused by spinal motor neuron demise leadin...
Autores principales: | Günther, René, Wurster, Claudia Diana, Cordts, Isabell, Koch, Jan Christoph, Kamm, Christoph, Petzold, Daniel, Aust, Elisa, Deschauer, Marcus, Lingor, Paul, Ludolph, Albert Christian, Hermann, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838202/ https://www.ncbi.nlm.nih.gov/pubmed/31736847 http://dx.doi.org/10.3389/fneur.2019.01098 |
Ejemplares similares
-
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment
por: Freigang, Maren, et al.
Publicado: (2021) -
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
por: Osmanovic, Alma, et al.
Publicado: (2021) -
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy
por: Binz, Camilla, et al.
Publicado: (2022) -
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
por: Wurster, Claudia D., et al.
Publicado: (2019) -
Intrathecal nusinersen administration in adult spinal muscular
atrophy patients with complex spinal anatomy
por: Cordts, Isabell, et al.
Publicado: (2020)